Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 121 results for "claris lifesciences"

IPO: Wonderla's profit ratios attractive, says Fernando

Wonderla Holidays: Promoter's pedigree justifies price-band though IPO's success hinges on managers' skill! Even while as many as 37 SMEs succeeded in listing their shares during the fiscal 2014 notwithstanding many of them having questionable ... Moneycontrol.com, 2 days ago

5 images for claris lifesciences

Money Control, 1 month ago
Money Control, 1 month ago
Financial Express, 3 months ago
Oneindia, 3 months ago
Financial Express, 3 months ago

FIIs discretion

Sectors and stocks whose fortunes are tied to a turnaround in the domestic economy have been in focus in the hope rally that has lifted equity benchmarks seven per cent this year, but overseas portfolio investors are looking elsewhere: discretionary ...
 Financial Chronicle2 days ago

India's overseas borrowings more than triples in February

Mumbai - Showing signs of uptick and confidence in Indian business environment, external commercial borrowing (ECB) by Indian companies rose to $4.3 billion in February 2014. The borrowing by Indian firms via this route were at $1.79 billion in the ...
 Oneindia1 week ago February ECBs rise to $4.3 bn on business uptick  Hindu Business Line2 weeks ago Better biz environment ups India ECB borrowings at $4.3b in Feb  The Financial Chronicle2 weeks ago Better biz environ ups India ECB borrowings in Feb  Economic Times1 week ago
[x]  
Money Control

Claris Lifesciences gains more than 8% intraday on buyback approval

Shares of Claris Lifesciences gained more than 8% intraday after the drugmaker said that the equity shareholders of the company had approved the Rs 231 crore buyback. "The equity shareholders of the company have approved the buy back of up to ...
 Financial Express1 month ago Claris Life jumps 8% on shareholders' nod for buyback offer  Money Control1 month ago Claris Lifesciences rallies over 8% on share buyback plan  Economic Times1 month ago Claris Lifesciences surges on share buyback plan  Business Standard1 month ago
[x]  

Claris Lifesciences to buy-back 14.49% stake from shareholders for Rs 231.25 crore

Claris Lifesciences will buy-back shares aggregating 14.49% of its total equity capital from shareholders for a total of Rs 231.25 crore. The company will buy-back up to 92.5 lakh shares of face value Rs 10 each at a price of Rs 250. As on February ...
 Indian-Commodity1 month ago Claris to buy-back 14.49 per cent stake for Rs 231.25 crore  Economic Times1 month ago Claris to buy-back 14.49% stake for Rs 231.25 cr  Business Standard1 month ago

Claris Lifesciences Ltd Fixes Record Date for Buy Back of Equity Shares

The Buy Back Committee (constituted by the Board of Directors of Claris Lifesciences Ltd at its meeting held on January 07, 2014), at its meeting held on March 20, 2014, has approved April 02, 2014 as the record date for the purpose of determining ...
 Equity Bulls1 month ago Claris Lifesciences fixes record date for buyback of equity shares  Money Control1 month ago Claris Lifesciences announces record date for share buyback  Capital Market1 month ago Claris gets USFDA nod to market Furosemide injection  Business Standard2 months ago

Claris Lifesciences: Updates on buyback offer

Claris Lifesciences is going to buy back of upto 92,50,000 fully paid up Equity Shares of Face Value of Rs 10 each at a price of Rs 250 per fully paid up Equity Share on a proportionate basis through the Tender Offer Process.
 Money Control1 month ago Claris Lifesciences to buy back 14.5% shares through tender offer  PharmaBiz1 month ago

Claris Lifesciences posts consolidated revenues at Rs 7,084 million

EBITDA margin at Rs 2,100 million Claris Lifesciences announced its annual audited financial results for the year ended December 31, 2013 at its recently held board meeting at its registered office in Ahmedabad. The consolidated revenues for the ...
 Express Pharma1 month ago Claris Lifesciences net down 18%  Business Line1 month ago Claris Lifesciences cons revenue at 7,084 Mn  India Infoline1 month ago Claris FY13 net down 18% to Rs 84 cr  Business Line1 month ago

Claris Lifesciences dips over 7% on heavy volumes

The company has fixed April 02 as the record date for purpose of buyback offer.
 Business Standard3 weeks ago
[x]  
Money Control

Claris Lifesciences consolidated net profit at Rs. 18 cr in Q4

Claris Lifesiciences, a Rs. 650 crore pharmaceutical company from Ahmedabad, has posted consolidated net profit of Rs. 17.75 crore during the fourth quarter ended December 2013 from Rs. 25.19 crore in the corresponding period of last year. These ...
 PharmaBiz1 month ago Claris Lifesciences Q4 profit declines 29.50% to Rs 17.75 cr  Business Standard1 month ago Claris Lifesciences net profit declines 15.29% in the December 2013 quarter  HDFC Securities1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - claris lifesciences
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less